Baker Avenue Asset Management LP Invests $288,000 in Grail, Inc. (NASDAQ:GRAL)

Baker Avenue Asset Management LP acquired a new stake in Grail, Inc. (NASDAQ:GRAL - Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 16,112 shares of the company's stock, valued at approximately $288,000.

Several other large investors also recently modified their holdings of the stock. FNY Investment Advisers LLC bought a new position in Grail in the fourth quarter valued at approximately $26,000. State of Tennessee Department of Treasury bought a new position in shares of Grail in the 4th quarter valued at $28,000. Lindbrook Capital LLC acquired a new position in shares of Grail during the 4th quarter worth $28,000. Sterling Capital Management LLC bought a new position in Grail in the fourth quarter valued at about $29,000. Finally, Wellington Shields Capital Management LLC bought a new stake in shares of Grail during the fourth quarter worth about $33,000.

Insider Buying and Selling at Grail

In other Grail news, CFO Aaron Freidin sold 1,816 shares of the stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $31.20, for a total value of $56,659.20. Following the transaction, the chief financial officer now owns 335,170 shares in the company, valued at approximately $10,457,304. This represents a 0.54 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Robert P. Ragusa sold 7,625 shares of the company's stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $31.21, for a total value of $237,976.25. Following the transaction, the chief executive officer now directly owns 828,662 shares in the company, valued at $25,862,541.02. The trade was a 0.91 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 194,948 shares of company stock valued at $6,583,130.

Grail Trading Down 2.5 %

Shares of GRAL traded down $0.90 during trading hours on Friday, hitting $35.20. 878,412 shares of the stock were exchanged, compared to its average volume of 1,223,599. Grail, Inc. has a fifty-two week low of $12.33 and a fifty-two week high of $63.99. The business has a 50-day moving average of $29.67 and a 200-day moving average of $25.56.

Grail (NASDAQ:GRAL - Get Free Report) last announced its earnings results on Thursday, February 20th. The company reported ($1.86) EPS for the quarter, beating the consensus estimate of ($4.41) by $2.55. The business had revenue of $38.25 million for the quarter, compared to the consensus estimate of $35.33 million. On average, sell-side analysts predict that Grail, Inc. will post -15.15 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on GRAL shares. Morgan Stanley lifted their target price on shares of Grail from $16.00 to $20.00 and gave the stock an "equal weight" rating in a research report on Tuesday, March 18th. Canaccord Genuity Group assumed coverage on Grail in a report on Monday, April 21st. They issued a "buy" rating and a $32.00 price objective for the company.

Grail Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.